Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Host Directed Therapies For Tuberculosis
Download Host Directed Therapies For Tuberculosis full books in PDF, epub, and Kindle. Read online Host Directed Therapies For Tuberculosis ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Host-Directed Therapies for Tuberculosis by : Vishwanath Venketaraman
Download or read book Host-Directed Therapies for Tuberculosis written by Vishwanath Venketaraman and published by MDPI. This book was released on 2020-11-20 with total page 120 pages. Available in PDF, EPUB and Kindle. Book excerpt: TB is considered as one of the oldest documented infectious diseases in the world and is believed to be the leading cause of mortality due to a single infectious agent. Mtb, the causative agent responsible for TB, continues to afflict millions of people worldwide. Furthermore, one-third of the entire world's population has latent TB. Consequently, there has been a worldwide effort to eradicate and limit the spread of Mtb through the use of antibiotics. However, management of TB is becoming more challenging with the emergence of drug-resistant and multi-drug resistant strains of Mtb. Furthermore, when administered, many of the anti-TB drugs commonly present severe complications and side effects. Novel approaches to enhance the host immune responses to completely eradicate Mtb infection are urgently needed. This Special Issue will therefore cover most recent advances in the area of host-directed therapies for TB.
Book Synopsis Advances in Host-Directed Therapies Against Tuberculosis by : Petros C. Karakousis
Download or read book Advances in Host-Directed Therapies Against Tuberculosis written by Petros C. Karakousis and published by Springer Nature. This book was released on 2020-12-03 with total page 325 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book discusses specific immune cell regulatory pathway(s), immune cell types, or other mechanisms involved in host responses to tuberculosis that can be potentially targeted for host-directed therapy (HDT). The pathways/mechanisms investigated are either protective – thus calling for pathway/factor enhancing drugs – or maladaptive – thus calling for pathway/factor inhibitory drugs. Discovery and development (pre-clinical and clinical) of candidate HDT agents will also be elucidated, as well as approaches for HDT of other diseases. The benefit to the reader will derive from learning about the biology of multiple host pathways involved in health and disease, how these pathways are disrupted or dysregulated during tuberculosis, and which druggable targets exist in these pathways. This book provides the reader with a roadmap of current and future directions of HDT against tuberculosis. Since the host pathways/factors involved in protective or maladaptive responses to tuberculosis are not disease-specific, information learned from the context of tuberculosis likely will be relevant to other infectious and non-infectious diseases.
Book Synopsis Host-Directed Therapies for Tuberculosis by : Vishwanath Venketaraman
Download or read book Host-Directed Therapies for Tuberculosis written by Vishwanath Venketaraman and published by . This book was released on 2020 with total page 120 pages. Available in PDF, EPUB and Kindle. Book excerpt: TB is considered as one of the oldest documented infectious diseases in the world and is believed to be the leading cause of mortality due to a single infectious agent. Mtb, the causative agent responsible for TB, continues to afflict millions of people worldwide. Furthermore, one-third of the entire world's population has latent TB. Consequently, there has been a worldwide effort to eradicate and limit the spread of Mtb through the use of antibiotics. However, management of TB is becoming more challenging with the emergence of drug-resistant and multi-drug resistant strains of Mtb. Furthermore, when administered, many of the anti-TB drugs commonly present severe complications and side effects. Novel approaches to enhance the host immune responses to completely eradicate Mtb infection are urgently needed. This Special Issue will therefore cover most recent advances in the area of host-directed therapies for TB.
Book Synopsis Nanotechnology Based Approaches for Tuberculosis Treatment by : Prashant Kesharwani
Download or read book Nanotechnology Based Approaches for Tuberculosis Treatment written by Prashant Kesharwani and published by Academic Press. This book was released on 2020-06-10 with total page 284 pages. Available in PDF, EPUB and Kindle. Book excerpt: Nanotechnology Based Approaches for Tuberculosis Treatment discusses multiple nanotechnology-based approaches that may help overcome persisting limitations of conventional and traditional treatments. The book summarizes the types of nano drugs, their synthesis, formulation, characterization and applications, along with the most important administration routes. It also explores recent advances and achievements regarding therapeutic efficacy and provides possible future applications in this field. It will be a useful resource for investigators, pharmaceutical researchers, innovators and scientists working on technology advancements in the areas of targeted therapies, nano scale imaging systems, and diagnostic modalities in tuberculosis. Addresses the gap between nanomedicine late discovery and early development of tuberculosis therapeutics Explores tuberculosis nanomedicine standardization and characterization with newly developed treatment, diagnostic and treatment monitoring modalities Covers the field thoroughly, from the pathogenesis of tuberculosis and multi-drug resistant mycobacterium tuberculosis, to treatment approaches using nanotechnology and different nanocarriers
Book Synopsis Disease Control Priorities, Third Edition (Volume 6) by : King K. Holmes
Download or read book Disease Control Priorities, Third Edition (Volume 6) written by King K. Holmes and published by World Bank Publications. This book was released on 2017-11-06 with total page 506 pages. Available in PDF, EPUB and Kindle. Book excerpt: Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.
Book Synopsis Tuberculosis Drug Discovery and Development 2019 by : Giovanna Riccardi
Download or read book Tuberculosis Drug Discovery and Development 2019 written by Giovanna Riccardi and published by MDPI. This book was released on 2020-11-24 with total page 296 pages. Available in PDF, EPUB and Kindle. Book excerpt: Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis and still represents one of the global health threats to mankind. The World Health Organization estimated more than 10 million new cases and reported more than 1.5 million deaths in 2019, thus ranking TB among the main causes of death due to a single pathogen. Standard anti-TB therapy includes four first-line antibiotics that should be administered for at least six months. However, in the case of multi- and extensively drug-resistant TB, second-line medications must be used and these frequently cause severe side effects resulting in poor compliance. Developing new anti-TB drug candidates is therefore of outmost importance. In this Special Issue dedicated to Tuberculosis Drug Discovery and Development, we present the main and latest achievements in the fields of drug and target discovery, host-directed therapy, anti-virulence drugs, and describe the development of two advanced compounds: macozinone and delpazolid. In addition, this Special Issue provides an historical perspective focused on Carlo Forlanini, the inventor of pneumothorax for TB treatment, and includes an overview of the state-of-the-art technologies which are being exploited nowadays in TB drug development. Finally, a summary of TB vaccines that are either approved or undergoing clinical trials concludes the Special Issue.
Book Synopsis Understanding the Host Immune Response Against Mycobacterium tuberculosis Infection by : Vishwanath Venketaraman
Download or read book Understanding the Host Immune Response Against Mycobacterium tuberculosis Infection written by Vishwanath Venketaraman and published by Springer. This book was released on 2018-09-26 with total page 144 pages. Available in PDF, EPUB and Kindle. Book excerpt: According to the World Health Organization, approximately one third of the world’s population is latently infected with Mycobacterium tuberculosis (M. tb [LTBI]), of whom about 9 million have active tuberculosis (TB). It is estimated that approximately 2 million individuals die each year from active TB. An estimated 14.4% of these individuals have HIV and M. tb co-infection. TB has long been known to be one of the leading causes of death in HIV-infected individuals. Recent evidence now indicates that individuals with type 2 diabetes, the elderly, and chronic smokers are also increasingly susceptible to TB infection, the ability of their immune system to fight off active TB infection having been compromised by their condition. This book therefore aims to provide a detailed review of recent advances in the research that involves characterizing the host’s immune responses against TB infection in conditions such as HIV, diabetes, chronic cigarette smoking and aging, and strategies to restore favorable immune responses against this deadly pathogen.
Book Synopsis Beyond Antibiotics: Exploring Host-Directed Therapy for TB by : Jessy
Download or read book Beyond Antibiotics: Exploring Host-Directed Therapy for TB written by Jessy and published by Tredition Gmbh. This book was released on 2024-05-16 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Tuberculosis (TB) remains a global health crisis, with drug-resistant strains posing a growing threat. Traditional antibiotics face limitations in treatment length and resistance development. A revolutionary approach called Host-Directed Therapy (HDT) is emerging. HDT doesn't target the bacteria directly, but instead strengthens the body's own defenses against TB. Imagine boosting the immune system's ability to fight the infection and prevent its persistence. This not only tackles existing TB strains but also holds promise for reducing the risk of relapse and the formation of drug-resistant bacteria. Early research on HDT is encouraging. By unlocking the body's natural TB-fighting potential, this approach could revolutionize TB treatment, offering a much-needed weapon in the fight against this devastating disease.
Book Synopsis Towards Host-Directed Drug Therapies for Infectious and Non-Communicable Diseases by : Frank Brombacher
Download or read book Towards Host-Directed Drug Therapies for Infectious and Non-Communicable Diseases written by Frank Brombacher and published by Frontiers Media SA. This book was released on 2019-11-25 with total page 138 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Natural Resistance to and Host-Directed Prevention of Tuberculosis by : Robert Wilkinson
Download or read book Natural Resistance to and Host-Directed Prevention of Tuberculosis written by Robert Wilkinson and published by Frontiers Media SA. This book was released on 2020-06-16 with total page 161 pages. Available in PDF, EPUB and Kindle. Book excerpt: Tuberculosis remains an important bacterial disease responsible for more than one million deaths per year. The risk of overt disease is highest in the first year post infection, nevertheless, asymptomatic chronic infection (referred to as Latent Tuberculosis Infection, LTBI) may also be established. LTBI cannot be ascertained directly, it can only be inferred from a skin or blood test of immune sensitization. Nevertheless, it is often stated that one third of the world’s population has LTBI. The central tenet of Tuberculosis control has therefore been antibiotic treatment of overt disease and the selective less intensive antibiotic treatment of patients considered at risk of progression of LTBI. Much Tuberculosis research has been directed towards elucidation of the mechanisms of host susceptibility to disease. The best-characterized immune risk factor for Tuberculosis is HIV-1 co-infection. Others include anti-TNF therapies, Diabetes Mellitus, other forms of immunosuppression, and cigarette smoking. However in most clinical cases of Tuberculosis, no underlying immunological defect can be identified. Since the general assumption is that most people infected with Tuberculosis never develop disease, this suggests that most people who are exposed and infected with Mycobacterium tuberculosis harbor immunity to Tuberculosis. This encourages the hypothesis that vaccination should be possible and indeed Bacille Calmette Guérin (BCG) vaccination confers protection against disseminated disease in children. However, BCG vaccination is not associated with reduced pulmonary disease in adults, which is a significant limitation. Furthermore it has been recognized that increased resistance to Tuberculosis occurs in specific populations. These include (i) heavily exposed persons in whom tests of immune sensitization nevertheless remain persistently negative; (ii) children aged between 5 years and puberty, and (iii) persons with documented persistent positive tests of sensitization who nevertheless never manifest disease. As progress towards the elimination of Tuberculosis is insufficient under current antibiotic-based strategies, the idea to enhance immune resistance either via improved vaccination or enhanced natural immunity is important. Recent research interest has therefore increased attention on the analysis of resistance in humans. The current BCG vaccine is conventionally thought to prevent progression of established infection. However, vaccination strategies now also envisage the prevention of infection and relapse. There has been a rapid growth of interest in adjunctive host-directed immune interventions which aim to either enhance protective immunity or to regulate pathological tissue-damaging immunity. However, the idea of host-directed prevention is less widely discussed.
Book Synopsis Targeting Cellular Signalling Pathways in Lung Diseases by : Kamal Dua
Download or read book Targeting Cellular Signalling Pathways in Lung Diseases written by Kamal Dua and published by Springer Nature. This book was released on 2021-07-02 with total page 926 pages. Available in PDF, EPUB and Kindle. Book excerpt: The book comprehensively reviews and provides detailed insight into the cellular and molecular signalling mechanisms involved in pathophysiology of various respiratory diseases, towards developing effective therapeutic strategies in the management and treatment of lung disease. It also covers promising advances in the field of therapeutics that could lead to novel clinical therapies capable of preventing or reversing the disease features including novel strategies for targeting chronic lung diseases using advanced drug delivery systems. Importantly, the book examines the significance and relevance of the plant extracts and their constituents with therapeutic efficiencies against lung diseases. As such, the book offers a blend of translational, biological, chemical, and drug delivery aspects relevant to respiratory diseases, thus, offering a valuable resource for pulmonologists and translational researchers working in the field of pulmonary biology and respiratory medicine.
Book Synopsis Mycobacterium Tuberculosis Pathogenesis, Infection Prevention and Treatment by : Davide Maria Ferraris
Download or read book Mycobacterium Tuberculosis Pathogenesis, Infection Prevention and Treatment written by Davide Maria Ferraris and published by . This book was released on 2020 with total page 128 pages. Available in PDF, EPUB and Kindle. Book excerpt: Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the Special Issue entitled “Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment” that includes 7 research articles and a review. The scientific contributions included in the Special Issue mainly focus on the characterization of MTB strains emerging in TB endemic countries as well as on multiple mechanisms adopted by the bacteria to resist and to adapt to antitubercular therapies.
Book Synopsis Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions by : Seyed Ehtesham Hasnain
Download or read book Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions written by Seyed Ehtesham Hasnain and published by Springer. This book was released on 2020-12-27 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book reviews recent advances in the molecular and infection biology, pathology, and molecular epidemiology of Mycobacterium tuberculosis, as well as the identification and validation of novel molecular drug targets for the treatment of this mycobacterial disease. Despite being completely curable, tuberculosis is still one of the leading global causes of death. M. tuberculosis, the causative organism – one of the smartest pathogens known – adopts highly intelligent strategies for survival and pathogenesis. Presenting a wealth of information on the molecular infection biology of M. tuberculosis, as well as nontuberculous mycobacteria (NTM), the book provides an overview of the functional role of the PE/PPE group of proteins, which is exclusive to the genus Mycobacteria, of host-pathogen interactions, and virulence. It also explores the pathogenesis of the infection, pathology, epidemiology, and diagnosis of NTM. Finally it discusses current and novel approaches in vaccine development against tuberculosis, including the role of nanotechnology. With state-of-the-art contributions from experts in the respective domains, this book is an informative resource for practitioners as well as medical postgraduate students and researchers.
Book Synopsis Tuberculosis in Adults and Children by : Dorothee Heemskerk
Download or read book Tuberculosis in Adults and Children written by Dorothee Heemskerk and published by Springer. This book was released on 2015-07-17 with total page 66 pages. Available in PDF, EPUB and Kindle. Book excerpt: This work contains updated and clinically relevant information about tuberculosis. It is aimed at providing a succinct overview of history and disease epidemiology, clinical presentation and the most recent scientific developments in the field of tuberculosis research, with an emphasis on diagnosis and treatment. It may serve as a practical resource for students, clinicians and researchers who work in the field of infectious diseases.
Book Synopsis Persister Cells and Infectious Disease by : Kim Lewis
Download or read book Persister Cells and Infectious Disease written by Kim Lewis and published by Springer Nature. This book was released on 2019-11-13 with total page 295 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume is a collection of chapters from the leading experts in the relatively new and burgeoning field of persister cell studies. Persisters play a leading role in the recalcitrance of chronic infections, and enable the development of classical antibiotic resistance. The focus of the book is on studies that provide an understanding of the mechanisms of persister formation, antibiotic tolerance and role in disease, at the molecular level.
Book Synopsis Tuberculosis of the Central Nervous System by : Mehmet Turgut
Download or read book Tuberculosis of the Central Nervous System written by Mehmet Turgut and published by Springer. This book was released on 2017-06-13 with total page 633 pages. Available in PDF, EPUB and Kindle. Book excerpt: Written and edited by leading international authorities in the field, this book provides an in-depth review of knowledge of tuberculosis of the central nervous system, with emphasis on clinical, diagnostics, and therapeutic features. Tuberculosis, one of the most lethal diseases in human history, still poses a serious threat in the world together with economic and social problems, although a great progress in the fight against this infectious disease in the last century. It covers the full range of tuberculosis of central nervous system and the chapters are organized into six sections: (1) the cranial; (2) the spinal; and (3) the peripheral portions of the nervous system; followed by (4) a section on the laboratory studies in tuberculosis; (5) a section on medical and surgical therapy; and (6) further insights into tuberculosis. This comprehensive reference book will be an ideal source for neurosurgeons, neurologists and specialists upon infectious diseases seeking both basic and more sophisticated information and surgical procedures relating to the complications associated with tuberculosis involving the spine, brain and peripheral nerves.
Download or read book HIV-related TB. written by and published by . This book was released on 1993 with total page 20 pages. Available in PDF, EPUB and Kindle. Book excerpt:
